<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="CAD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>CA-3-M012569002</iati-identifier>
  <reporting-org ref="CA-3" type="10">
   <narrative xml:lang="FR">Affaires &#xE9;trang&#xE8;res, Commerce et D&#xE9;veloppement Canada (MAECD)</narrative>
   <narrative xml:lang="EN">Foreign Affairs, Trade and Development Canada (DFATD)</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Advance Market Commitment for Pneumococcal Vaccines (II)</narrative>
   <narrative xml:lang="FR">M&#xE9;canisme de garantie de march&#xE9;s pour le vaccin antipneumococcique (II)</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Le m&#xE9;canisme de garantie de march&#xE9;s (MGM) est un engagement financier de divers donateurs pour aider &#xE0; financer l&#x2019;achat futur de vaccins contre la pneumococcie, une des principales causes de mortalit&#xE9; chez les enfants atteints d&#x2019;une pneumonie ou d&#x2019;une m&#xE9;ningite dans les pays en d&#xE9;veloppement. La pneumococcie entra&#xEE;ne plus de 1,7 million de d&#xE9;c&#xE8;s par ann&#xE9;e, dont pr&#xE8;s de 90 % se produisent dans les pays en d&#xE9;veloppement et 50 % touchent des enfants de moins de cinq ans.  Le MGM est une fa&#xE7;on novatrice de prot&#xE9;ger la vie des enfants les plus pauvres au monde en offrant des vaccins plus rapidement dans les pays en d&#xE9;veloppement. Le m&#xE9;canisme consiste &#xE0; mettre de l&apos;argent de c&#xF4;t&#xE9; pour garantir l&apos;achat de vaccins une fois qu&apos;ils sont d&#xE9;velopp&#xE9;s, &#xE0; condition qu&apos;ils r&#xE9;pondent aux crit&#xE8;res &#xE9;tablis particuli&#xE8;rement pour les pays en d&#xE9;veloppement. Le MGM vise &#xE0; inciter les fabricants de vaccins &#xE0; acc&#xE9;l&#xE9;rer leur d&#xE9;veloppement et &#xE0; les vendre &#xE0; des prix abordables aux pays pauvres. Le MGM devrait permettre de sauver environ 7 millions de vies d&apos;ici 2030.  Au total, les donateurs se sont engag&#xE9;s &#xE0; verser 1,5 milliard de dollars am&#xE9;ricains au MGM. Ces fonds permettent &#xE0; la Banque mondiale et au GAVI Alliance de mettre en oeuvre le MGM. La contribution totale du Canada en faveur du MGM est de 200 millions de dollars am&#xE9;rcains, dont 115 millions de dollars canadiens ont &#xE9;t&#xE9; d&#xE9;bours&#xE9;s. Ce projet repr&#xE9;sente la balance de la contribution canadienne, d&#xE9;bours&#xE9;e pour r&#xE9;pondre &#xE0; la demande des pays pour les vaccins antipneumococciques.</narrative>
   <narrative xml:lang="EN">The Advance Market Commitment (AMC) is a financial commitment by multiple donors to help pay for the future purchase of a vaccine for pneumococcal disease, a leading cause of child deaths from pneumonia and meningitis in developing countries. Pneumococcal disease is responsible for more than 1.7 million deaths per year. Of these deaths, almost 90% occur in developing countries, and half occur among children under age five.  The AMC is an innovative way to protect the lives of the world&#x2019;s poorest children by making vaccines available in developing countries more quickly. It is based on the concept of putting money aside to guarantee the purchase of vaccines once they are developed as long as they meet criteria specifically set out for the developing world. It aims to stimulate vaccine makers to accelerate the production of vaccines for developing countries and sell them at prices that poor countries can afford. The AMC is expected to save an estimated 7 million lives by 2030.  The total donor commitment to the AMC is US$1.5 billion. These funds allow for the implementation of the AMC concept by the World Bank and the GAVI Alliance. Canada&apos;s total commitment to the AMC is US$200 million, of which C$115 million have been disbursed. This project represents the balance of Canada&apos;s contribution, which is disbursed based on country demand for pneumococcal vaccines.</narrative>
  </description>
  <participating-org crs-channel-code="44006" ref="XM-DAC-44006" role="4" type="40">
   <narrative xml:lang="EN">Advance Market Commitments</narrative>
   <narrative xml:lang="FR">Advance Market Commitments</narrative>
  </participating-org>
  <participating-org ref="CA" role="1" type="10">
   <narrative xml:lang="EN">Canada</narrative>
   <narrative xml:lang="FR">Canada</narrative>
  </participating-org>
  <participating-org ref="CA-1" role="3" type="10">
   <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
   <narrative xml:lang="EN">Canadian International Development Agency</narrative>
  </participating-org>
  <other-identifier ref="2017202090" type="A2"></other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2010-04-13" type="2"></activity-date>
  <activity-date iso-date="2021-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Affaires &#xE9;trang&#xE8;res, Commerce et D&#xE9;veloppement Canada (MAECD)</narrative>
    <narrative xml:lang="EN">Foreign Affairs, Trade and Development Canada (DFATD)</narrative>
   </organisation>
   <email>info@international.gc.ca</email>
   <website>www.international.gc.ca</website>
   <mailing-address>
    <narrative xml:lang="EN">125 Sussex Drive, Ottawa, Ontario, K1A 0G2</narrative>
    <narrative xml:lang="FR">125, promenade Sussex, Ottawa (Ontario), K1A 0G2</narrative>
   </mailing-address>
  </contact-info>
  <recipient-region code="298" percentage="25" vocabulary="1"></recipient-region>
  <recipient-region code="498" percentage="25" vocabulary="1"></recipient-region>
  <recipient-region code="798" percentage="25" vocabulary="1"></recipient-region>
  <recipient-region code="89" percentage="25" vocabulary="1"></recipient-region>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <policy-marker code="10" significance="0" vocabulary="99" vocabulary-uri="https://www.international.gc.ca/department-ministere/open_data-donnees_ouvertes/dev/data_field_definitions-definitions_champs_donnees.aspx?lang=eng#a2">
   <narrative xml:lang="EN">Adolescent (Youth) Issues</narrative>
   <narrative xml:lang="FR">Questions touchant les adolescents (jeunes)</narrative>
  </policy-marker>
  <policy-marker code="9" significance="0" vocabulary="99" vocabulary-uri="https://www.international.gc.ca/department-ministere/open_data-donnees_ouvertes/dev/data_field_definitions-definitions_champs_donnees.aspx?lang=eng#a2">
   <narrative xml:lang="EN">Children&apos;s issues</narrative>
   <narrative xml:lang="FR">Questions touchant les enfants</narrative>
  </policy-marker>
  <policy-marker code="13" significance="0" vocabulary="99" vocabulary-uri="https://www.international.gc.ca/department-ministere/open_data-donnees_ouvertes/dev/data_field_definitions-definitions_champs_donnees.aspx?lang=eng#a2">
   <narrative xml:lang="EN">ICT as a tool for development</narrative>
   <narrative xml:lang="FR">Les TIC comme outils de d&#xE9;veloppement</narrative>
  </policy-marker>
  <policy-marker code="11" significance="0" vocabulary="99" vocabulary-uri="https://www.international.gc.ca/department-ministere/open_data-donnees_ouvertes/dev/data_field_definitions-definitions_champs_donnees.aspx?lang=eng#a2">
   <narrative xml:lang="EN">Indigenous issues</narrative>
   <narrative xml:lang="FR">Questions touchant les populations autochtones</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="99" vocabulary-uri="https://www.international.gc.ca/department-ministere/open_data-donnees_ouvertes/dev/data_field_definitions-definitions_champs_donnees.aspx?lang=eng#a2">
   <narrative xml:lang="FR">Questions urbaines</narrative>
   <narrative xml:lang="EN">Urban issues</narrative>
  </policy-marker>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="B02" vocabulary="1"></default-aid-type>
  <budget status="2" type="1">
   <period-start iso-date="2017-04-01"></period-start>
   <period-end iso-date="2018-03-31"></period-end>
   <value currency="CAD" value-date="2010-04-13">0</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2010-07-26"></transaction-date>
   <value currency="CAD" value-date="2010-07-26">20468404.3</value>
   <receiver-org ref="XM-DAC-44006"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2010-08-31"></transaction-date>
   <value currency="CAD" value-date="2010-08-31">-209547.12</value>
   <receiver-org ref="XM-DAC-44006"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2011-07-14"></transaction-date>
   <value currency="CAD" value-date="2011-07-14">22859222.6</value>
   <receiver-org ref="XM-DAC-44006"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2011-07-31"></transaction-date>
   <value currency="CAD" value-date="2011-07-31">66797.98</value>
   <receiver-org ref="XM-DAC-44006"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2012-07-18"></transaction-date>
   <value currency="CAD" value-date="2012-07-18">-24745482.74</value>
   <receiver-org ref="XM-DAC-44006"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2012-07-18"></transaction-date>
   <value currency="CAD" value-date="2012-07-18">24745482.74</value>
   <receiver-org ref="XM-DAC-44006"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2012-07-30"></transaction-date>
   <value currency="CAD" value-date="2012-07-30">24504170.41</value>
   <receiver-org ref="XM-DAC-44006"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2012-08-21"></transaction-date>
   <value currency="CAD" value-date="2012-08-21">-60937.46</value>
   <receiver-org ref="XM-DAC-44006"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2013-07-12"></transaction-date>
   <value currency="CAD" value-date="2013-07-12">-16612800</value>
   <receiver-org ref="XM-DAC-44006"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2013-07-12"></transaction-date>
   <value currency="CAD" value-date="2013-07-12">16612800</value>
   <receiver-org ref="XM-DAC-44006"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2013-07-22"></transaction-date>
   <value currency="CAD" value-date="2013-07-22">17000000</value>
   <receiver-org ref="XM-DAC-44006"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-07-16"></transaction-date>
   <value currency="CAD" value-date="2014-07-16">10945031.84</value>
   <receiver-org ref="XM-DAC-44006"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-08-06"></transaction-date>
   <value currency="CAD" value-date="2014-08-06">-29465.83</value>
   <receiver-org ref="XM-DAC-44006"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-08-06"></transaction-date>
   <value currency="CAD" value-date="2014-08-06">-29465.83</value>
   <receiver-org ref="XM-DAC-44006"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-08-08"></transaction-date>
   <value currency="CAD" value-date="2014-08-08">29465.83</value>
   <receiver-org ref="XM-DAC-44006"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2010-04-13"></transaction-date>
   <value currency="CAD" value-date="2010-04-13">95543676.73</value>
   <flow-type code="10"></flow-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <document-link format="TEXT/HTML" url="http://w05.international.gc.ca/projectbrowser-banqueprojets/project-projet/details/M012569002?Lang=eng">
   <title>
    <narrative xml:lang="EN">Description</narrative>
   </title>
   <category code="A02"></category>
   <category code="A08"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="http://w05.international.gc.ca/projectbrowser-banqueprojets/project-projet/details/M012569002?Lang=fra">
   <title>
    <narrative xml:lang="FR">Description</narrative>
   </title>
   <category code="A02"></category>
   <category code="A08"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://search.open.canada.ca/en/gc/?sort=score%20desc&amp;page=1&amp;search_text=M012569002">
   <title>
    <narrative xml:lang="FR">Proactive disclosure</narrative>
   </title>
   <category code="A06"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://rechercher.ouvert.canada.ca/fr/gc/?sort=score desc&amp;page=1&amp;search_text=M012569002">
   <title>
    <narrative xml:lang="FR">Divulgation proactive</narrative>
   </title>
   <category code="A06"></category>
   <language code="FR"></language>
  </document-link>
  <related-activity ref="CA-3-M012569001" type="3"></related-activity>
  <conditions attached="0"></conditions>
  <result type="2">
   <title>
    <narrative xml:lang="EN">Results achieved</narrative>
    <narrative xml:lang="FR">R&#xE9;sultats atteints</narrative>
   </title>
   <indicator measure="5">
    <title>
     <narrative xml:lang="EN">Results achieved</narrative>
     <narrative xml:lang="FR">R&#xE9;sultats atteints</narrative>
    </title>
    <description>
     <narrative xml:lang="FR">Parmi les principaux r&#xE9;sultats obtenus par le M&#xE9;canisme de garantie de march&#xE9; de la GAVI avec le soutien du Canada et d&#x2019;autres donateurs internationaux en 2011 et 2012 : Au total, 101 millions de doses ont &#xE9;t&#xE9; produites et administr&#xE9;es. Ainsi, plus de 10 millions d&#x2019;enfants dans 24 pays ont &#xE9;t&#xE9; immunis&#xE9;s contre la principale cause de la pneumonie.</narrative>
     <narrative xml:lang="EN">Results achieved by GAVI&#x2019;s Advance Market Commitment through the support of Canada and other international donors during the period of 2010 to 2012 include: a total of 101 million doses produced and delivered, culminating in an estimated number of over 10 million children in 24 countries immunized against today&#x2019;s main cause of pneumonia.</narrative>
    </description>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
